Mednet Logo
CommunityNeurology

What patient factors most strongly influence your decision to start biologic agents in mild cognitive impairment?

Specifically, what guidelines do you use to help determine this (if any)?
1 Answer
Mednet Member
Mednet Member
Neurology · Mount Sinai Medical Center
Answered on

1.Absence of need for anticoagulants ( this is exclusionary)

2. Absence of APOE e4 homozygosity (although we do treat e4 homozygotes, but with much greater precautionary measures - especially the dosing protocol)

3. High functional ability, and adherence to healthy lifestyle measures (exercise, die...

Join for free or sign in to see the full answer